Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115791) titled 'Clinical Efficacy and Safety of Hepatic Arterial Infusion Chemotherapy Combined with Systemic Therapy in Patients with Unresectable Intrahepatic Cholangiocarcinoma Refractory to First-Line Treatment' on Dec. 31, 2025.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: The second affiliated hospital of nanchang university
Condition:
Intrahepatic Cholangiocarcinoma
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-01
Target Sample Size: Hepatic Arterial Infusion Chemotherapy (HAIC):40;
Countries of Recruitment:
China
To know more, visit https://www...